Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of IDEXX Laboratories Inc. IDXX shed 1.38% to $457.35 Wednesday, on what proved to be an all-around poor trading ...

Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $435 and keeps a Neutral rating on the shares. The firm ...

The Wednesday morning market activity shows IDEXX Laboratories shares down by 0.74%, trading at $460.32. This implies a total value of $4,280,728 for Fennell's 11,242 shares.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...